Escavite LQ

Directions for Use

Dosage and administration: 1 mL daily, or as prescribed. Includes easy to use dropper. To administer directly, place the dropper directly inside child's mouth that the tip against the inside of the cheek. A firm pressure on the dropper bulb will deliver the proper dose. A slight excess will remain in the dropper. If preferred the drops may be slowly mixed with formula, juice, cereal or other food and fed within 1 hour.

Shake well. Use calibrated dropper.

Formulation Notes

Liquid multi-vitamin supplement with iron and flouride 0.25 mg

Indications and usage: Supplementation of the diet with nine essential vitamins and iron, and supplementation of the diet with fluoride for caries prophylaxis.

Escavite LQ Multi-vitamin with Iron and Fluoride 0.25 mg provides fluoride in drop form for infants and young children from 6 months to 3 years of age in areas where the drinking water contains less than 0.3 ppm of fluoride and for children ages 3-6 years in areas where the drinking water contains 0.3 through 0.6 ppm of fluoride.2,3 Each 1.0 ml supplies sodium fluoride (0.25 mg fluoride per 1 mL) plus nine essential vitamins and iron. Escavite LQ Multi-vitamin with Iron and Fluoride 0.25 mg supplies significant amounts of vitamins A,C,D,E, thiamin, riboflavin, niacin, vitamin B6, vitamin B12, and iron to supplement the diet, and to help assure the deficiencies of these nutrients will not develop. Thus, in a single easy-to-use preparation, infants and children obtain nine essential vitamins and iron, plus fluoride.

How supplied: Escavite LQ Multi-Vitamin with Iron and Fluoride 0.25 mg drops is an orange to dark orange liquid with an orange odor available in 50 mL bottles with accompanying calibrated dropper.

Occasional deepening of color has no significant effect on vitamin potency. While taking drops with iron, a slight darkening of the teeth may occur. Brushing will minimize this temporary condition.

Active ingredient for caries prophylaxis: Each 1 mL contains 0.25 mg fluoride as sodium fluoride.

Additional Information

Rx only

Professional labeling Clinical Pharmacology: It is well established that fluoridation of the water supply (1ppm fluoride) during the period of tooth development leads to a significant decrease in the incidence of dental caries. Hydroxyapatite is the principal crystal for all calcified tissue in the human body. The fluoride ion reacts with the hydroxyapatite in the tooth as it is formed to produce the more caries-resistant crystal, fluorapatite. Three stages of fluoride deposition in tooth enamel can be distinguished:1 1) Small amounts (reflecting the low levels of fluoride in tissue fluids) are incorporated into the enamel crystals while they are being formed. 2) After enamel has been laid down, fluoride deposition continues in the surface enamel. Diffusion of fluoride from the surface inward is apparently restricted. 3) After eruption, the surface enamel acquires fluoride from water, food, supplementary fluoride, and smaller amounts from saliva.

The American Academy of Pediatrics recommends that children up to age 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplementation.

(Product code: 58809-877-50)

Storage: Store at 25 degrees C (77 degrees F); excursions permitted to 15-30 degrees C (59-86 degrees F). See USP controlled room temperature. Protect from light and moisture. Close tightly after each use.

After opening, store away from direct light.

Your doctor or dentist is the best source of counsel and guidance in your child's fluoride supplementation.

References: 1. Brudevold F, McCann HG. Fluoride and caries control - Mechanism of action. In: Nizel AE, ed. The Science of Nutrition and Its Application in Clinical Dentistry. Philadelphia: WB Saunders Co.; 1966;331-347. 2. American Academy of Pediatrics, Committee on Nutrition: Fluoride Supplementation for Children: Interim Policy Recommendations. AAP News, February 1995, pg 18. 3. American Dental Association Council on Dental Therapeutics. New Fluoride Schedule Adopted. ADA News. May 16, 1994;12-14 Manufactured for: GM Pharmaceuticals, Inc., Arlington, TX 76015 Covered by U.S. Patent No. 7,341,708.